ORPHENADRINE vs OSIMERTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ORPHENADRINE vs OSIMERTINIB: Safety Overview
| Metric | ORPHENADRINE | OSIMERTINIB |
|---|---|---|
| Total FAERS Reports | 584 | 27,750 |
| Deaths Reported | 121 | 12,456 |
| Death Rate | 20.7% | 44.9% |
| Hospitalizations | 159 | 5,277 |
| Average Patient Age | 47.9 yrs | 68.2 yrs |
| % Female Patients | 79.3% | 66.0% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | Nov 13, 2015 |
| Manufacturer | Sandoz Inc | AstraZeneca Pharmaceuticals LP |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |